Gene-Specific Epigenetic Programming of WNT Signaling Pathway by Dietary Soy

膳食大豆对 WNT 信号通路进行基因特异性表观遗传编程

基本信息

  • 批准号:
    7640719
  • 负责人:
  • 金额:
    $ 7.42万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-09-01 至 2011-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Colon cancer is one of the most frequently diagnosed cancers in the United States. Poor prognosis also makes it one of the deadliest cancers. Dietary factors are closely associated with tumorigenesis and development of colon cancer. Soy foods and soy bioactive components have been linked to lower colon cancer incidence in populations consuming large quantity of soy foods. However there are controversies and mechanisms by which soy products and soy bioactive components exert anticancer effects remain unknown. Because of lack of scientific evidence on the mechanisms of soy foods' cancer prevention potentials, there are no nutritional recommendations made to Americans. Based on current knowledge of colon cancer and preliminary data on beneficial actions of soy foods, the present proposal will test the hypothesis that dietary soy modulates colon cancer development through epigenetic programming at specific genes of WNT signaling pathway. An early maternal exposure model will be used for epigenetic programming by soy foods in colon of offspring rats. Using techniques including methylation analysis of CpG islands and chromatin immunoprecipitation coupled to a pathway-specific microarray, specific aims in this proposal include: 1) to identify specific genes along the WNT signaling pathway that are modified epigenetically by maternal soy diets; 2) to determine the extent to which the WNT pathway is affected in colon in rats by soy foods; and 3) to monitor protection from getting colon cancer in later life of offspring rats with life long exposure to soy foods. Findings from this project will improve our understandings on anticancer mechanisms of soy products at epigenetic level and facilitate future experimental design for further research on soy foods and colon cancer prevention. PUBLIC HEALTH RELEVANCE: Findings from this project will improve our understandings on anticancer mechanisms of soy products at epigenetic level and aid future experimental design for further research on soy foods and colon cancer prevention. Data obtained will facilitate translational research in the future to define dietary recommendations for soy foods for American populations.
描述(由申请人提供):结肠癌是美国最常诊断的癌症之一。预后不良也使其成为最致命的癌症之一。饮食因素与结肠癌的发生、发展密切相关。大豆食品和大豆生物活性成分与食用大量大豆食品的人群中结肠癌发病率降低有关。然而,大豆制品和大豆生物活性成分发挥抗癌作用的机制仍不清楚,存在争议。由于缺乏关于大豆食品预防癌症潜力机制的科学证据,没有向美国人提出营养建议。基于目前对结肠癌的认识和大豆食品有益作用的初步数据,本提案将验证膳食大豆通过WNT信号通路特定基因的表观遗传编程调节结肠癌发展的假设。早期母体暴露模型将用于后代大鼠结肠中大豆食物的表观遗传编程。使用包括CpG岛甲基化分析和染色质免疫沉淀与途径特异性微阵列偶联在内的技术,该提案的具体目标包括:1)鉴定沿着WNT信号通路被母体大豆饮食表观遗传修饰的特定基因; 2)确定大豆食品对大鼠结肠中WNT途径的影响程度;和3)监测终身暴露于大豆食品的后代大鼠在以后的生活中免受结肠癌的保护。本研究的发现将有助于我们在表观遗传学水平上对大豆制品的抗癌机制的理解,并为大豆食品和结肠癌预防的进一步研究提供实验设计。公共卫生相关性:本研究的发现将有助于我们在表观遗传学水平上对大豆制品的抗癌机制的理解,并为大豆食品和结肠癌预防的进一步研究提供实验设计。所获得的数据将促进未来的转化研究,以确定美国人口的大豆食品的饮食建议。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hong Chen其他文献

Hong Chen的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hong Chen', 18)}}的其他基金

Sonogenetics 2.0
声遗传学2.0
  • 批准号:
    10734960
  • 财政年份:
    2023
  • 资助金额:
    $ 7.42万
  • 项目类别:
Role of PXR in drug-elicited cardiovascular disease
PXR 在药物引起的心血管疾病中的作用
  • 批准号:
    10576675
  • 财政年份:
    2022
  • 资助金额:
    $ 7.42万
  • 项目类别:
Sonobiopsy for Noninvasive Genetic Evaluation of Glioblastoma Patients
声活检对胶质母细胞瘤患者进行无创基因评估
  • 批准号:
    10564014
  • 财政年份:
    2022
  • 资助金额:
    $ 7.42万
  • 项目类别:
The Role of Adaptor Protein Disabled-2 in Maintaining Endothelial Cell Function in Atherosclerosis
接头蛋白Disabled-2在维持动脉粥样硬化内皮细胞功能中的作用
  • 批准号:
    10532247
  • 财政年份:
    2021
  • 资助金额:
    $ 7.42万
  • 项目类别:
iSonogenetics for incisionless cell-type-specific neuromodulation of non-human primate brains
非人类灵长类大脑的无切口细胞类型特异性神经调节的声遗传学
  • 批准号:
    10655585
  • 财政年份:
    2021
  • 资助金额:
    $ 7.42万
  • 项目类别:
The Role of Adaptor Protein Disabled-2 in Maintaining Endothelial Cell Function in Atherosclerosis
接头蛋白Disabled-2在维持动脉粥样硬化内皮细胞功能中的作用
  • 批准号:
    10391797
  • 财政年份:
    2021
  • 资助金额:
    $ 7.42万
  • 项目类别:
Molecular Mechanisms Governing Vascular Cell Function and Phenotype in Health and Disease
健康和疾病中控制血管细胞功能和表型的分子机制
  • 批准号:
    10600825
  • 财政年份:
    2021
  • 资助金额:
    $ 7.42万
  • 项目类别:
iSonogenetics for incisionless cell-type-specific neuromodulation of non-human primate brains
非人类灵长类大脑的无切口细胞类型特异性神经调节的声遗传学
  • 批准号:
    10270569
  • 财政年份:
    2021
  • 资助金额:
    $ 7.42万
  • 项目类别:
Focused ultrasound-enabled brain tumor liquid biopsy (FUS-LBx) supplement
聚焦超声脑肿瘤液体活检 (FUS-LBx) 补充剂
  • 批准号:
    10448708
  • 财政年份:
    2021
  • 资助金额:
    $ 7.42万
  • 项目类别:
Molecular Mechanisms Governing Vascular Cell Function and Phenotype in Health and Disease
健康和疾病中控制血管细胞功能和表型的分子机制
  • 批准号:
    10380102
  • 财政年份:
    2021
  • 资助金额:
    $ 7.42万
  • 项目类别:

相似海外基金

Investigating the functions of histone acetylation in genome organization and leukemogenesis
研究组蛋白乙酰化在基因组组织和白血病发生中的功能
  • 批准号:
    EP/Y000331/1
  • 财政年份:
    2023
  • 资助金额:
    $ 7.42万
  • 项目类别:
    Research Grant
Gene Modulation of Acetylation Modifiers to Reveal Regulatory Links to Human Cardiac Electromechanics
乙酰化修饰剂的基因调节揭示与人类心脏机电的调节联系
  • 批准号:
    10677295
  • 财政年份:
    2023
  • 资助金额:
    $ 7.42万
  • 项目类别:
Novel roles of PDK2 in heart failure: Regulation of mitochondrial nuclear crosstalk via metabolic regulation and histone acetylation
PDK2 在心力衰竭中的新作用:通过代谢调节和组蛋白乙酰化调节线粒体核串扰
  • 批准号:
    10635599
  • 财政年份:
    2023
  • 资助金额:
    $ 7.42万
  • 项目类别:
Regulation of hepatic lysine N-acetylation by cysteine proximity due to alcohol toxicity
酒精毒性导致的半胱氨酸接近对肝脏赖氨酸 N-乙酰化的调节
  • 批准号:
    10752320
  • 财政年份:
    2023
  • 资助金额:
    $ 7.42万
  • 项目类别:
Histone Acetylation Regulates Microglial Innate Immune Memory
组蛋白乙酰化调节小胶质细胞先天免疫记忆
  • 批准号:
    478927
  • 财政年份:
    2023
  • 资助金额:
    $ 7.42万
  • 项目类别:
    Operating Grants
Dysregulation of Histone Acetylation in Parkinson's Disease
帕金森病中组蛋白乙酰化的失调
  • 批准号:
    10855703
  • 财政年份:
    2023
  • 资助金额:
    $ 7.42万
  • 项目类别:
Obesity-related hypertension: the contribution of PPAR gamma acetylation and asprosin
肥胖相关高血压:PPAR γ 乙酰化和白脂素的贡献
  • 批准号:
    10654210
  • 财政年份:
    2023
  • 资助金额:
    $ 7.42万
  • 项目类别:
The role N-terminal acetylation in dilated cardiomyopathy and associated arrhythmia
N-末端乙酰化在扩张型心肌病和相关心律失常中的作用
  • 批准号:
    10733915
  • 财政年份:
    2023
  • 资助金额:
    $ 7.42万
  • 项目类别:
In vivo tracing of hepatic ethanol metabolism to histone acetylation: role of ACSS2 in alcohol-induced liver injury
肝脏乙醇代谢与组蛋白乙酰化的体内追踪:ACSS2 在酒精性肝损伤中的作用
  • 批准号:
    10667952
  • 财政年份:
    2023
  • 资助金额:
    $ 7.42万
  • 项目类别:
The function of TWIST1 acetylation in cell fate and tissue development
TWIST1 乙酰化在细胞命运和组织发育中的作用
  • 批准号:
    10726986
  • 财政年份:
    2023
  • 资助金额:
    $ 7.42万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了